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Abstract
Background: Visceral leishmaniasis (VL) is a protozoan diseases caused in Europe by Leishmania
(L.) infantum. Asymptomatic Leishmania infection is more frequent than clinically apparent disease.
Among HIV infected patients the risk of clinical VL is increased due to immunosuppression, which
can reactivate a latent infection. The aims of our study were to assess the prevalence of
asymptomatic L. infantum infection in HIV infected patients and to study a possible correlation
between Leishmania parasitemia and HIV infection markers.
Methods: One hundred and forty-five HIV infected patients were screened for the presence of
anti-Leishmania antibodies and L. infantum DNA in peripheral blood. Statistical analysis was carried
out by using a univariate regression analysis.
Results: Antibodies to L. infantum were detected in 1.4% of patients. L. infantum DNA was
detected in 16.5% of patients. Significant association for PCR-Leishmania levels with plasma viral
load was documented (p = 0.0001).
Conclusion: In our area a considerable proportion of HIV infected patients are asymptomatic
carriers of L. infantum infection. A relationship between high HIV viral load and high parasitemic
burden, possibly related to a higher risk of developing symptomatic disease, is suggested. PCR could
be used for periodic screening of HIV patients to individuate those with higher risk of reactivation
of L. infantum infection.
Background
Leishmaniasis is a group of protozoan diseases, transmit-
ted by the bite of a sandfly infected with Leishmania para-
sites, and including cutaneous, mucocutaneous and
visceral manifestations. In Europe visceral leishmaniasis
(VL) is caused by Leishmania (L.)infantum and is transmit-
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ted through a zoonotic mechanism which involves the
dog as the main reservoir of the infection. It has been esti-
mated that in endemic countries the number of asympto-
matic  Leishmania  infections in immunocompetent
persons is 5-10 times greater than the number of clinically
apparent VL disease cases [1].
Much attention has been given to Leishmania/HIV coinfec-
tion during the last decade. Among patients with AIDS the
risk of clinical VL is increased by 100-1000 times due to
immunosuppression, which can reactivate a latent infec-
tion [2]. It is often mentioned in the literature that 25-
70% of all VL cases in the Mediterranean countries are
HIV-positive. Moreover, VL treatment is a challenge in
these patients because of frequent relapses despite an ade-
quate therapy. During the last years the incidence of VL in
HIV infected patients in south western Europe is dramati-
cally diminished due to the use of Highly Active Antiret-
roviral Therapy. Nevertheless, the carriage of L. infantum
in peripheral blood has been proven in asymptomatic
HIV-infected patients and in patients with an opportunis-
tic infections other than VL [3,4].
Serological methods are useful for diagnosing VL in
immunocompetent patients, but they always require a
parasitological confirmation by direct detection of Leish-
mania amastigotes in bone marrow biopsy samples by
microscopic observation, culture or polymerase chain
reaction (PCR). Furthermore, serological tests are of lim-
ited value in HIV-associated VL, where their diagnostic
sensitivity is much lower.
During the last years a number of noninvasive methods
have been developed for the diagnosis of Leishmania infec-
tion. PCR-based methods for detecting Leishmania species
have been used for testing peripheral blood and urine
samples [5-7]. Particularly, PCR assays performed on
peripheral blood samples have been confirmed as a useful
tool for the diagnosis of VL in both immunocompetent
and immunocompromised patients [5,8].
The aims of our study were to assess the prevalence of
asymptomatic  L. infantum infection in HIV infected
patients living in our geographic area and to study a pos-
sible correlation between Leishmania parasitemia and HIV
infection markers.
Methods
One hundred and forty-five HIV infected patients
attended at infectious disease department of Policlinico in
Palermo (Italy) in the period February-May 2008 were
invited to participate in a prevalence study. All 145
patients after giving their consent were screened for both
the presence of anti-Leishmania antibodies and L. infantum
DNA in peripheral blood. From all patients demographic
and clinical data were collected. In particular, information
regarding the previous occurrence of symptomatic VL
were asked. The study was carried out in compliance with
the Helsinki declaration.
Serological analysis
Serum samples were analyzed for the presence of anti-
Leishmania IgG antibodies by an immunofluorescent anti-
body test (IFAT) and an enzyme-linked immunosorbent
assay (ELISA).
For IFAT, a laboratory-made antigen was used to increase
test sensitivity [9]. Promastigotes of L. infantum zymo-
deme MON1 were propagated in Medium 199 (Gibco,
Milan, Italy) supplemented with 25 mM Hepes (Gibco,
Milan, Italy) and 10% fetal calf serum (Gibco, Milan,
Italy). After 48 hours of incubation at 26°C, whole para-
sites were collected by centrifugation and washed three
times in cold phosfate-buffered saline (PBS). For IFAT,
whole parasite were fixed on slides (Bio-Merieux Italia,
Rome, Italy), diluted in PBS until to obtain 30-40 para-
sites for microscopic field. For IFAT we used the fluores-
cein-conjugated anti-human immunoglobulin IgG (KPL
Gaithersburg, USA). The optimal working concentration
was 1:100 in PBS.
For ELISA, soluble leishmanial antigen was prepared by
ultrasonic lysed and by cycles of freezing and thawing of a
suspension of parasites. The optimal protein concentra-
tion was 0,2 μg/well, as previously reported [10]. We used
for ELISA, anti-human IgG labelled with alkaline phos-
phatase (SIGMA- Aldrich srl, Milano, Italy); the optimal
working concentration was 1:5000 in PBS. The cut-off
points for IgG was defined as the arithmetical mean OD
of sera of blood donors + 3 standard deviations (0.300).
Both for IFAT and ELISA, all samples showing positivity at
a dilution ≥1/50 were considered to be reactive.
DNA extraction
DNA was extracted from cultured IPT1 MON1 Leishmania
promastigotes (to construct the standard curve), and from
human blood samples. The IPT1, taken from the collec-
tion of the Italian National Reference Centre for leishma-
niasis (C.Re.Na.L), were grown in Tobie agar medium,
Evans modified [11,12]. Stationary-phase promastigotes
were harvested by centrifugation, washed in NaCl 0.3%,
and enumerated with a Thoma hemacytometer. Finally
the pelleted parasites were resuspended in PBS at 1 × 109/
ml final concentration and employed for DNA extraction.
The cells were again pelleted at 4.000 rpm for 15 min, and
homogenized in 1 ml of lysis mix, (1% Tween 20, 1%
Non idet P-40, e 20% Chelex). The mixture was incubated
at 96°C for 20 min until complete lysis. After 10 min cen-
trifugation at 14000 rpm we collected the liquid contain-BMC Infectious Diseases 2009, 9:199 http://www.biomedcentral.com/1471-2334/9/199
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ing the extracted DNA. The examined human samples,
were 200 μl of whole blood, that were extracted by "Illus-
tra blood genomic Prep mini Spin kit (GE)" according to
the manufacturer instruction.
TaqMan PCR
The PCR test was targeted on a 68 bp fragment inner the
constant region in the mini circle kinetoplast DNA
(kDNA) (NCBI accession number AF291093) and was
carried out as previously described [13]. The primers and
probe were chosen with the assistance of Primer express
software (Applied Biosystem). The primer sequences
were: QLK2-U 5'-GGCGTTCTGCGAAAACCG-3'; QLK2-
D5'-AAAATGGCATTTTCGGGCC-3'; while the associated
probe was: 5'-TGGGTGCAGAAATCCCGTTCA-3' 5'FAM
and 3' TAMRA labelled. We introduced a reaction quality
internal control system supplied by the "TaqMan exoge-
nous internal positive control reagents kit" (Applied Biosys-
tem), labelled with a "VIC" fluorochrome. Each
amplification was performed in duplicate, in 25 μl reac-
tion mixture containing 1× TaqMan Universal Master Mix
(Applied Biosystem), 100 pmol/μl of the specific primers
and 10 pmol/μl of labelled probe (Qleish 2), 1× EXO IPC
Mix, 1× EXO IPC DNA according to the manufacturer's
instructions of the TaqMan Exogenus Internal Positive
Control Reagents kit (Applied Biosystem). The thermal
cycling conditions comprised an initial incubation for 2'
at 50°C for uracyl-N-glycosylase activity. This step was fol-
lowed by a 10' denaturation at 95°C and 45 cycles at
95°C for 15" and 60°C for 1' each. The quantity of DNA
in the samples examined was detected by comparison of
the Ct values plotted on common log scale.
Results were expressed as parasite charge for ml of the liq-
uid matrices as blood, according to the parasite charge per
ml of the standard curve described below. The efficiency
of the amplification was always close to 1. Reproducibility
was previously estimated by testing each dilution of the
standard DNA for 18 times in each analytical plate. Three
replicates of six different concentrations of L. infantum
DNA were tested in the same run and the experiment was
done four times, (72 test totally); in this way we per-
formed intra-assay and inter-assay comparison of the
obtained signal for each DNA concentrations. The repro-
ducibility was always 100% for each analytical point of
the standard curve ranging from the DNA equivalent of 1
× 106 cells to 1 cell for μl. We detected the limit of the sen-
sitivity, by testing decimal serial dilutions of the standard
DNA below to 1 parasite equivalent per ml. Reproducibil-
ity of the PCR Leishmania test was 100% at a level of DNA
concentration corresponding to 0.1 parasites/ml, which
was considered the threshold for positive samples.
Standard curve
A standard stock DNA solution was obtained by extrac-
tion of 1 ml PBS containing 1 × 109 IPT1 MON1 promas-
tigotes as described above. We performed decimal serial
dilutions of the stock solution to obtain the points of the
curve ranging from the DNA equivalent of 1 × 106 cells to
1 cell for μl. The difference for each point of the curve was
one log factor. The DNA concentration was estimated by
spectrophotometric determination of A260 and A280. and
by gel electhrophoresis. On the basis of the linearity in the
fluorescent signal trough the serial standard DNA dilu-
tions, PCR test and dedicated software (SDS Applied Bio-
systems) permitted us to detect parasitic charge lower than
1 cell/ml (minimum of the curve).
Statistical analysis
Data were expressed as median and range unless other-
wise specified. Linear regression analysis examined the
correlation between CD4 count, plasma viral load (inde-
pendent variables), and L. infantum kDNA levels (depend-
ent variable) in the HIV infected patients. These
continuous variables were assessed in univariate linear
regression model. All P-values were two-sided and P-val-
ues less than 0.05 were considered statistically significant.
Data were analyzed by the Epi Info software (version 6.0,
Centers for Disease Control and Prevention, Atlanta, GA,
USA) and SPSS Software (version 14.0, SPSS Inc, Chicago,
IL, USA).
Results
The study population comprised 145 patients, 99 males
and 46 females. The median age was 43 years (range 22-
70 years). One hundred and thirty-three blood samples
were obtained from asymptomatic patients who consecu-
tively referred to our Infectious Diseases ambulatory.
Twelve blood samples belonged to HIV infected patients
admitted to our Infectious Diseases department with
symptoms not consistent with VL: 5 patients were admit-
ted for pneumopathy, 2 for endocarditis, 2 for urinary
tract infection, 1 for tuberculosis, 1 for Kaposi's sarcoma
and 1 for neurotoxoplasmosis. Median CD4 cells count
was 430 cells/mm3 (range 7-1264). Viral load was unde-
tectable (<47 HIV RNA copies/ml) in 52 patients. One
hundred and fourteen patients assumed antiretroviral
therapy. Only one patient reported a previous diagnosis of
VL 5 years before, that was successfully treated with lipo-
somal amphotericin B.
Specific IgG antibodies to L. infantum were detected both
by ELISA and IFAT method in 2/145 (1.4%) patients.
L. infantum kDNA was detected by PCR in 24/145
(16.5%) asymptomatic patients. Parasitemia was detected
also in one additional patient, who had been admitted for
neurotoxoplasmosis, and during the hospitalization
developed severe anemia and splenomegaly. For this rea-
son he was treated with intravenous liposomal amphoter-
icin B and was excluded by analysis.BMC Infectious Diseases 2009, 9:199 http://www.biomedcentral.com/1471-2334/9/199
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Parasitemia ranged between 0.12 and 1500 parasites/ml
with a median of 9 parasites/ml (table 1). Median CD4
cell count was 432 cells/mm3 (range 36-945). HIV viral
load ranged between <47 and >1000000 copies/ml with a
median of 150 copies/ml (figures 1, 2). All parasitemic
patients but 2 (patients 12, 13) were HIV infected outpa-
tients attending our Infectious Diseases ambulatory.
Patient 12 was affected by urinary tract infection; patient
13 was affected by pneumopathy.
We performed univariate linear regression analysis to esti-
mate the association of L. infantum kDNA levels (depend-
Table 1: Characteristics of 24 HIV infected patients with asymptomatic Leishmania infantum parasitemia
Pt no. Sex Age Previous VL CD4 (cells/mm3) Viral load (copies/ml) ELISA IFAT PCR (parasites/ml)
1 m 39 No 492 <47 neg Neg 1
2 m 32 No 306 1450 neg Neg 0.24
3 m 46 No 450 70 neg Neg 2
4 f 42 No 178 600 neg Neg 0.12
5 m 43 No 840 <47 neg Neg 10
6 f 37 No 106 200 neg Neg 10
7 m 42 No 588 70000 neg Neg 100
8 f 33 No 446 1400 neg Neg 40
9 f 48 No 773 <47 neg Neg 20
10 m 33 No 95 87000 neg Neg 15
11 m 45 No 158 330 neg Neg 10
12 m 53 No 277 120 neg Neg 5
13 m 37 No 52 87000 neg Neg 300
14 m 50 2003 40 >1000000 1:400 1:1600 1500
15 m 29 No 36 180 neg Neg 400
16 f 43 No 418 <47 neg Neg 20
17 m 43 No 574 <47 neg Neg 5
18 m 41 No 120 <47 1:400 1:800 2
19 m 42 No 756 <47 neg Neg 5
20 f 48 No 674 18500 neg Neg 8
21 f 43 No 582 140000 neg Neg 4
22 m 49 No 279 <47 neg Neg 10
23 m 54 No 945 <47 neg Neg 5
24 f 53 No 726 <47 neg Neg 8BMC Infectious Diseases 2009, 9:199 http://www.biomedcentral.com/1471-2334/9/199
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ent variable) with the number of CD4 cells and plasma
viral load (independent variables) in the HIV infected
patients. Univariate regression analysis showed a signifi-
cant association for PCR levels with plasma viral load (p =
0.0001) but not with CD4 cells (p = 0.061) (table 2).
Patients who tested positive for L. infantum kDNA were
tested again on the subsequent ambulatory visit. Until
now, six patients have been retested. In five of them, PCR
was negative and CD4 cells count was higher than the first
determination, or almost the same; the last patient had an
increased parasitemia level accompanied by a reduced
CD4 cells count.
Discussion
VL is a relatively common disease in Europe, its incidence
rates varying from 0.3 to 5.6/100000/year in the endemic
countries [14]. Italy accounts for a mean of 155 cases/
years with an incidence rate of 0.3/100000.
In the present study, specific IgG were detected only in 2/
24 (8.3%) PCR-positive patients. Currently, these patients
have neither fever, splenomegaly nor pancytopenia. The
first patient (table 1, patient 14) had been previously
cured for VL in 2003. The high parasitemia detected in this
patient could be caused by the recent worsening of his
CD4 cells count, so he is strictly monitored to survey a
possible reactivation of VL. The second patient (table 1,
patient 18) had no history of previous VL, and his para-
sitemia is very low, so the risk of a symptomatic VL is
probably low. Nevertheless, he will be monitored even if
his HIV infection seems to be quite controlled. As previ-
ously reported, there is no strict concordance between
serological and parasitological techniques for the detec-
tion of cryptic L. infantum infection [15,16]. Moreover
serological tests have been described as limited diagnostic
tools in HIV infected people, since only 40% of VL
patients appeared seropositive for leishmaniasis. This fact
is probably due to the pronounced disregulation of the
immune system that occurs in HIV infection [2,4].
Since immunosuppressed patients present a higher risk of
developing overt disease than immunocompetent people,
it is likely that the number of asymptomatic carriers of L.
infantum among HIV infected persons would be higher as
well. Our results highlight that in our geographic area a
considerable proportion (16.5%) of HIV infected patients
are asymptomatic carriers of L. infantum infection. A sim-
ilar screening performed in Spain found L. infantum DNA
in peripheral blood in 30.4% of 92 asymptomatic HIV
infected subjects [4]. The lower percentage of parasitemia
detected in our study could be attributable to a lower
prevalence of the asymptomatic leishmaniasis in our
endemic area. This is in accordance with the low incidence
of reported cases of VL in Italy, which is one of European
countries with a slight endemicity. Furthermore, recent
studies carried out in our region showed a low prevalence
of seropositivity for L. infantum in blood donors [17,18].
The cell-mediated immune response largely determines
the outcome of Leishmania infection, and therefore most
cases of overt VL in HIV patients occur when CD4 cells
count is under 200/mm3 [2,5,19]. Accordingly, while sev-
eral studies performed in HIV infected patients with VL
Distribution of Leishmania infantum parasitemias related to  CD4 cells count in 24 HIV infected patients, asymptomatic  for L. infantum infection Figure 1
Distribution of Leishmania infantum parasitemias 
related to CD4 cells count in 24 HIV infected 
patients, asymptomatic for L. infantum infection.
Distribution of Leishmania infantum parasitemias related to  HIV viral load in 24 HIV infected patients, asymptomatic for  L. infantum infection Figure 2
Distribution of Leishmania infantum parasitemias 
related to HIV viral load in 24 HIV infected patients, 
asymptomatic for L. infantum infection. pt = patients.BMC Infectious Diseases 2009, 9:199 http://www.biomedcentral.com/1471-2334/9/199
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reported a median CD4 cells count lower than 100 cells/
mm3 [5,19], our study together with previous observa-
tions shows that L. infantum infection can be asympto-
matic in HIV patients probably thanks to higher CD4 cells
counts [3,4]. The correlation between HIV-viral load and
parasitemia documented by our study (table 2) under-
lines the synergism between Leishmania and HIV.
Real- time PCR allows to quantify the number of parasites
circulating in peripheral blood. It has been reported that
the parasite burden in patients with VL and concomitant
HIV infection is similar to that found in immunocompe-
tent patients with VL [5,19]. However, we observed that
among HIV asymptomatic patients the median parasite
burden is lower than that detected in HIV patients with VL
[19]. This is consistent with our finding of a significant
association for PCR levels with plasma viral load (table 2),
and underlines the relationship between HIV and Leish-
mania  infections. In fact, those asymptomatic patients
with the higher PCR values also had high HIV viral load
(table 1). It is important to notice that the higher risk to
develop symptomatic VL which probably concerns these
patients would have not been recognized if the screening
for Leishmania infection would have been performed only
by serological analysis. These patients will undergo a
more strict survey towards the appearance of clinical and/
or laboratory signs of a reactivation of Leishmania infec-
tion. Until now none of parasitemic patients developed
symptomatic VL.
Finally, the median parasitemia in our group of HIV
infected patients resulted higher than that previously
reported in healthy subjects with cryptic Leishmania infec-
tion living in endemic areas [15]. This evidence is likely
due to immunological impairment, leading to a transitory
reactivation of cryptic Leishmania  infection resulting in
spikes of parasitemia higher than those detected in sub-
jects with asymptomatic Leishmania infection without HIV
coinfection.
Conclusion
In conclusion our findings seems to suggest a relationship
between high HIV viral load and high parasitemic burden
in HIV infected patients with cryptic L. infantum infection.
Hence, as showed by regression analysis, the plasma viral
load could be considered a good independent marker of a
increase in the PCR parasitemia levels. This association
could be related to a higher risk of developing sympto-
matic disease. However, further studies are needed to
assess the possible correlation between Leishmania para-
sitemia and HIV infection markers because the wide vari-
ability both in viral load and in parasitemia values,
together with the relatively small number of patients,
make difficult to establish a definitive relationship. Real-
time PCR could be considered a rapid and useful tool for
periodic screening of HIV infected asymptomatic patients,
in order to individuate those patients with higher risk of
reactivation of Leishmania infection and to survey the long
term outcomes of asymptomatic infections by L. infantum
in HIV infected patients.
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